Tirzepatide is supplied across more strengths than almost anything else in this catalogue, which makes vial sizing a real decision rather than a formality. The molecule is identical across all of them. What changes is how much of it is in the vial, and therefore how long an opened vial has to last.
This guide covers choosing a strength, reading the certificate for this compound specifically, and the three things that genuinely differ between suppliers offering what looks like the same product.
What tirzepatide is, structurally
A synthetic peptide engineered to engage two incretin receptors rather than one, built on a backbone related to naturally occurring incretin sequences with substitutions that change receptor engagement and resistance to the enzymes that would otherwise clear it quickly.
It also carries a fatty-acid chain attached to the backbone. That modification binds albumin and extends how long the molecule circulates, and it dominates the physical behaviour of the material in ways the receptor profile does not. Semaglutide, tirzepatide and retatrutide compared sets the three side by side.
Choosing a strength
Larger vials are cheaper per milligram and that saving is only real if the material is used before it degrades. For a compound supplied across seven strengths, the right question is not which is cheapest per milligram but which one a single piece of work consumes.
| Situation | Favours | Why |
|---|---|---|
| Evaluating a new supplier | The smallest strength | A first order is a test, not a commitment |
| Steady, predictable consumption | A larger strength | Per-milligram saving is realised |
| Occasional or exploratory work | The smallest strength | Avoids holding material that ages out |
| Several parallel pieces of work | Multiple smaller vials | Fewer entries per vial, less exchange of air |
| Long lead time on resupply | Mid strength, ordered earlier | Stock, not size, solves a lead-time problem |
The sizing question is consumption, not unit price. A vial half discarded was bought at full price.
Inventory levels and reorder points covers deriving that from measured consumption rather than from an estimate, and minimum order quantities covers what to do when the smallest order available exceeds what you can use.
What the certificate should show
The same panel as any other research peptide, read in the same order. Lot number first, against the vial. Then the two dates, which must run forwards. Then identity, then content, then purity.
For a long modified peptide like this one, the identity method matters more than it does for a short sequence. A single intact mass confirms the mass is consistent with the molecule. A method that fragments it and reads a ladder establishes considerably more, and mass spectrometry and peptide identity covers the difference.
Content, and why the label is the wrong number
The strength on the label is nominal. The certificate reports a measured mass of peptide, and fills are generally set to meet or slightly exceed the label, so the measured figure is often a few percent higher.
At these strengths a few percent is a real quantity, and it belongs in any calculation rather than the label figure. Net peptide content covers why the two differ and reconstitution arithmetic covers what follows.
Three things that genuinely vary between suppliers
- Whether the certificate names your lot or the product line. The first documents the vial you will receive; the second documents a vial someone else received.
- Whether identity is established by a method that reads a sequence, or only by a mass. Both are legitimate and they are not equivalent.
- Which salt form is supplied, which changes the mass of powder in the vial without changing the peptide. It is rarely on the certificate and it is always answerable by asking.
Comparing suppliers on documentation is the scoring method these roll up into, and it needs one email.
Reconstitution, and why this compound is slow
The acyl chain that extends circulation also makes the molecule more hydrophobic than its residue composition suggests. That is why tirzepatide and its class-mates are among the slower compounds in any catalogue to dissolve.
Material that appears not to be going into solution is usually behaving exactly as expected and needs time rather than force. Add solvent down the vial wall, swirl rather than shake, and let it stand. Shaking drives air into the solution and the air-water interface is where peptides unfold and associate.
Why some peptides resist dissolving covers the mechanism, and reconstitution solvents compared covers choosing a diluent.
Storage, before and after reconstitution
As a sealed dry solid this material is comparatively robust, because the water that most degradation routes need has been removed. The clock that matters starts at reconstitution rather than at delivery.
Once in solution, the usual controls apply and the number of entries into the vial matters as much as elapsed time. Freeze-thaw cycles and aliquoting covers protecting a reconstituted vial, and vial closures covers why entries are a limit.
What to check on arrival
- Lot number on every vial against the certificate supplied for it, reading the full string rather than the last few characters.
- The cake itself: a collapsed, shrunken or glassy cake is a finding worth raising, though it says nothing about identity or purity.
- Any temperature indicator, with the value recorded rather than the impression.
- That the quantity and strengths match the packing list before anything is put away.
Receiving and inspecting a peptide shipment is the ten-minute protocol this fits into.
What this guide deliberately does not cover
Anything about effects. Tirzepatide is supplied here strictly for laboratory research, and nothing in a buying guide speaks to outcomes in any organism. The published literature on this compound is extensive and is where that question belongs.
What a buyer can settle from documentation is narrower and more useful: which molecule is in the vial, how pure it is, how much of it there is, and whether the lot in front of them is the one the certificate describes.
Planning resupply rather than reacting to it
Lead times on this class are long enough that reactive ordering produces either a gap in the work or an emergency purchase at a worse price. The fix is to measure consumption for a quarter and set a reorder point from the measurement rather than from memory.
The complication specific to research material is that it degrades while it waits, so holding more stock buys exposure rather than security beyond a point. There is a ceiling as well as a floor, and the ceiling is whatever can be used inside the material usable window.
Comparing two quotes for the same compound
Normalise before comparing anything. Put both on the strength you will actually use, add shipping, add the cost of money for the terms offered, and only then divide. A quote two percent higher on thirty-day terms is cheaper than one two percent lower on prepayment for any practice not sitting on idle cash.
Where the two differ on documentation, treat the weaker one as carrying a cost you cannot price but should not ignore. How to read a wholesale peptide quote takes the four lines apart.
What to record once the material arrives
- The lot, read in full from the vial rather than from the packing slip.
- The certificate, downloaded and stored with your own records rather than linked to the supplier's archive.
- The measured content figure, since that is the number every later calculation uses.
- The salt form, which exists only in correspondence unless someone writes it down.
- The date of reconstitution and the count of entries, once the vial is opened.
Lot traceability and recordkeeping covers why the lot number is the field everything else hangs off.
A short pre-order checklist
Four questions, one email, about fifteen minutes. Can you send the certificate for a lot I would receive. Which laboratory issued it. Which salt form is supplied. What is the lead time for in stock versus made to order.
The answers matter and so does how they arrive: how quickly, whether they address what was asked, and whether they come from someone who can see the document. Comparing suppliers on documentation covers scoring the replies.
Why seven strengths exist at all
Because buyers consume at very different rates, and a single strength would force most of them into either waste or frequent reordering. A wide strength range is a convenience that transfers the sizing decision to the buyer, which is why it is worth making deliberately rather than by habit.
It also means two quotes for the same compound may not be comparing the same thing. Normalise to the strength you will actually use before comparing price, because per-milligram figures across different vial sizes are not directly comparable in practice.
In short
One molecule across seven strengths. Size against what a single piece of work consumes rather than against unit price, use the certificate content figure rather than the label, expect slow dissolution because of the acyl chain, and settle documentation before price.
A note on bundles
Where a compound is offered inside a bundle, the per-vial economics change and the documentation does not. Each vial in a bundle still carries its own lot and should still be traceable to a certificate naming that lot, and a bundle that supplies one document for several lots has not met that bar.
Check the lot count against the certificate count on arrival. It takes seconds and it is the commonest documentation gap in multi-item orders.
One final note on ordering across strengths. Where several strengths are bought together, confirm that each arrives with its own lot-matched certificate rather than one document covering the order, because a multi-strength delivery is the situation where that most often goes wrong.
This is one part of buying wholesale. Wholesale peptides for clinics covers the whole process from evaluating a supplier to placing a first order.